If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPRG.L Regulatory News (PRG)

  • There is currently no data for PRG

Rule 8.3- Premier Research Gr

20 May 2008 14:13

RNS Number : 8885U
Kaupthing Bank hf
20 May 2008
 



  FORM 8.3

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE 

(Rule 8.3 of the Takeover Code)

1. KEY INFORMATION

Name of person dealing  (Note 1)

Kaupthing Bank hf

Company dealt in

Premier Research Group

Class of relevant security to which the dealings being disclosed relate (Note 2)

Ordinary Shares

Date of dealing

19 May 2008

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Long

Short

Number (%)

Number (%)

(1) Relevant securities 

1,994 (0.003%)

(2) Derivatives (other than options)

1,853,516 (3.08%)

1,853,516 (3.08%)

(3) Options and agreements to purchase/sell

Total

1,853,516 (3.08%)

1,855,510 (3.09%)

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

Number (%)

Number (%)

(1) Relevant securities 

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

(c) Rights to subscribe (Note 3)

Class of relevant security:

Details

3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of securities

Price per unit (Note 5)

Sell

1,994

99.42p

 (b) Derivatives transactions (other than options)

Product name, 

e.g. CFD

Long/short (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise

price 

Type, e.g. American, European etc.

Expiry 

date

Option money

paid/received per unit (Note 5) 

(ii) Exercising

Product name, e.g. call option

Number of securities 

Exercise price per unit (Note 5)

(d) Other dealings (including new securities) (Note 4)

Nature of transaction (Note 8)

Details

Price per unit (if applicable) (Note 5)

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

No voting rights on CFD holdings

Is a Supplemental Form 8 attached? (Note 9) NO

Date of disclosure

20 May 2008

Contact name

Richard Easton

Telephone number

0203 205 6620

If a connected EFM, name of offeree/offeror with which connected

If a connected EFM, state nature of connection (Note 10)

Notes

The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETEADSEAFAPEFE
Date   Source Headline
31st Oct 20078:31 amRNSRule 8.3- Amendment
31st Oct 20078:31 amRNSRule 8.3 - Premier Research
31st Oct 20078:29 amRNSRule 8.3- Premier Research
31st Oct 20078:27 amRNSRule 8.3 - Premier Research
30th Oct 20079:32 amRNSEPT Disclosure
29th Oct 20073:40 pmRNSRule 8.3- (Premier Research)
29th Oct 20078:35 amRNSEPT Disclosure
26th Oct 200712:22 pmRNSRule 8.3- Premier Research Gp
26th Oct 200711:59 amRNSRule 8.3-Premier Research Gp
26th Oct 200710:07 amRNSEPT Disclosure
25th Oct 20073:32 pmRNSRule 8.3- Premier Research Gp
25th Oct 20078:37 amRNSEPT Disclosure
24th Oct 20072:00 pmRNSRule 8.3- Premier Research
24th Oct 20079:45 amRNSEPT Disclosure
23rd Oct 20073:01 pmRNSRule 8.3- Premier Research Gp
23rd Oct 20073:00 pmRNSRule 8.3- premier research
23rd Oct 200711:29 amRNSEPT Disclosure
22nd Oct 20079:07 amRNSEPT Disclosure
19th Oct 20073:26 pmRNSRule 8.3- (Premier Research)
19th Oct 200712:55 pmRNSInterim dividend-Amendment
19th Oct 200710:16 amRNSEPT Disclosure
19th Oct 20077:01 amRNSInterim Dividend
18th Oct 20073:14 pmRNSRule 8.3- Premier Research
18th Oct 20078:20 amRNSEPT Disclosure
18th Oct 20077:02 amRNSInterim Results
17th Oct 200710:08 amRNSEPT Disclosure
16th Oct 200710:23 amRNSEPT Disclosure
16th Oct 200710:11 amRNSNotification of Results
15th Oct 20072:50 pmRNSRule 8.3- Premier Research Gp
15th Oct 20078:57 amRNSEPT Disclosure
12th Oct 200710:59 amRNSRule 8.3- Premier Research Gp
12th Oct 20079:27 amRNSEPT Disclosure
11th Oct 200711:17 amRNSRule 8.3- Premier Research Gp
11th Oct 20079:35 amRNSEPT Disclosure
10th Oct 20072:23 pmRNSRule 8.3- PREMIER RESEARCH
9th Oct 20071:29 pmRNSRule 8.3- Premier Research Gp
9th Oct 20078:23 amRNSEPT Disclosure
8th Oct 20079:48 amRNSEPT Disclosure
5th Oct 200711:57 amRNSRule 8.3- Premier Research
5th Oct 200710:12 amRNSEPT Disclosure
4th Oct 20079:53 amRNSEPT Disclosure
3rd Oct 200712:55 pmRNSEPT Disclosure
2nd Oct 20079:53 amRNSEPT Disclosure
1st Oct 20078:18 amRNSEPT Disclosure
28th Sep 200711:04 amRNSRule 8.3- Premier Research
28th Sep 200710:25 amRNSEPT Disclosure
27th Sep 200712:01 pmRNSRule 8.3- Premier Research Gp
27th Sep 200710:25 amRNSRule 8.3-Premier Research Grp
27th Sep 20079:16 amRNSEPT Disclosure
26th Sep 20079:20 amRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.